199 related articles for article (PubMed ID: 29622131)
21. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Value of Nineteen Different Imaging Methods for Patients with Breast Cancer: a Network Meta-Analysis.
Zhang XH; Xiao C
Cell Physiol Biochem; 2018; 46(5):2041-2055. PubMed ID: 29723846
[TBL] [Abstract][Full Text] [Related]
23. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
Berg WA; Weinberg IN; Narayanan D; Lobrano ME; Ross E; Amodei L; Tafra L; Adler LP; Uddo J; Stein W; Levine EA;
Breast J; 2006; 12(4):309-23. PubMed ID: 16848840
[TBL] [Abstract][Full Text] [Related]
24. PET/MRI of the breast.
Plecha DM; Faulhaber P
Eur J Radiol; 2017 Sep; 94():A26-A34. PubMed ID: 28549570
[TBL] [Abstract][Full Text] [Related]
25. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer.
Tafra L; Cheng Z; Uddo J; Lobrano MB; Stein W; Berg WA; Levine E; Weinberg IN; Narayanan D; Ross E; Beylin D; Yarnall S; Keen R; Sawyer K; Van Geffen J; Freimanis RL; Staab E; Adler LP; Lovelace J; Shen P; Stewart J; Dolinsky S
Am J Surg; 2005 Oct; 190(4):628-32. PubMed ID: 16164937
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
[TBL] [Abstract][Full Text] [Related]
27. Whole-body MR or PET-CT?
Schmidt GP
Eur J Radiol; 2012 Sep; 81 Suppl 1():S142-3. PubMed ID: 23083566
[No Abstract] [Full Text] [Related]
28. Radiologist views of positron emission mammography.
Greene LR; George RF
Radiol Technol; 2012; 84(1):18-30. PubMed ID: 22988260
[TBL] [Abstract][Full Text] [Related]
29. Integrated PET/MR breast cancer imaging: Attenuation correction and implementation of a 16-channel RF coil.
Oehmigen M; Lindemann ME; Lanz T; Kinner S; Quick HH
Med Phys; 2016 Aug; 43(8):4808. PubMed ID: 27487899
[TBL] [Abstract][Full Text] [Related]
30. Developments in Breast Imaging: Update on New and Evolving MR Imaging and Molecular Imaging Techniques.
Heller SL; Heacock L; Moy L
Magn Reson Imaging Clin N Am; 2018 May; 26(2):247-258. PubMed ID: 29622129
[TBL] [Abstract][Full Text] [Related]
31. Positron emission mammography: high-resolution biochemical breast imaging.
Weinberg IN; Beylin D; Zavarzin V; Yarnall S; Stepanov PY; Anashkin E; Narayanan D; Dolinsky S; Lauckner K; Adler LP
Technol Cancer Res Treat; 2005 Feb; 4(1):55-60. PubMed ID: 15649088
[TBL] [Abstract][Full Text] [Related]
32. A preliminary report of breast cancer screening by positron emission mammography.
Yamamoto Y; Tasaki Y; Kuwada Y; Ozawa Y; Inoue T
Ann Nucl Med; 2016 Feb; 30(2):130-7. PubMed ID: 26586370
[TBL] [Abstract][Full Text] [Related]
33. Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT.
An YY; Kim SH; Kang BJ; Lee AW
J Korean Med Sci; 2015 Jun; 30(6):808-15. PubMed ID: 26028936
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values.
Sasaki M; Tozaki M; Kubota K; Murakami W; Yotsumoto D; Sagara Y; Ohi Y; Oosako S; Sagara Y
Jpn J Radiol; 2018 Feb; 36(2):122-133. PubMed ID: 29159779
[TBL] [Abstract][Full Text] [Related]
35. The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements.
Raylman RR; Majewski S; Smith MF; Proffitt J; Hammond W; Srinivasan A; McKisson J; Popov V; Weisenberger A; Judy CO; Kross B; Ramasubramanian S; Banta LE; Kinahan PE; Champley K
Phys Med Biol; 2008 Feb; 53(3):637-53. PubMed ID: 18199907
[TBL] [Abstract][Full Text] [Related]
36. PET/MR in Breast Cancer.
Tabouret-Viaud C; Botsikas D; Delattre BM; Mainta I; Amzalag G; Rager O; Vinh-Hung V; Miralbell R; Ratib O
Semin Nucl Med; 2015 Jul; 45(4):304-21. PubMed ID: 26050658
[TBL] [Abstract][Full Text] [Related]
37. An amorphous selenium based positron emission mammography camera with avalanche gain.
Reznik A; Lui BJ; Rowlands JA
Technol Cancer Res Treat; 2005 Feb; 4(1):61-7. PubMed ID: 15649089
[TBL] [Abstract][Full Text] [Related]
38. Clinical Applications of Dedicated Breast Positron Emission Tomography.
Fowler AM; Miyake KK; Nakamoto Y
PET Clin; 2024 Jan; 19(1):105-117. PubMed ID: 37805387
[TBL] [Abstract][Full Text] [Related]
39. Axillary lymph node characterization in breast cancer patients using magnetic resonance mammography: a prospective comparative study with FDG PET-CT and healthy women.
Krammer J; Wasser K; Schnitzer A; Henzler T; Schoenberg SO; Kaiser CG
Eur J Radiol; 2013 Dec; 82(12):2194-8. PubMed ID: 23993142
[TBL] [Abstract][Full Text] [Related]
40. Positron emission mammography in the diagnosis of breast cancer. Is maximum PEM uptake value a valuable threshold for malignant breast cancer detection?
Müller FH; Farahati J; Müller AG; Gillman E; Hentschel M
Nuklearmedizin; 2016; 55(1):15-20. PubMed ID: 26627876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
